Page last updated: 2024-09-05

erlotinib and Bladder Cancer

erlotinib has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cacaccio, J; Chandra, D; Cheruku, RR; Durrani, FA; El-Khouly, ME; Fukuzumi, S; Guru, K; Kumar, R; Marko, A; Missert, JR; Pandey, RK; Sajjad, M; Tabaczynski, WA; Watson, R; Yao, R1

Other Studies

1 other study(ies) available for erlotinib and Bladder Cancer

ArticleYear
Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy.
    Journal of medicinal chemistry, 2019, 03-14, Volume: 62, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mice; Mice, SCID; Photochemotherapy; Photosensitizing Agents; Positron-Emission Tomography; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2019